There were 1,779 press releases posted in the last 24 hours and 431,922 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image